Search
News
Downloads
About
Help
Contact
Entity Details
Primary name
AF1L2_HUMAN
Entity type
UniProt
Source
Source Link
Details
Accession
Q8N4X5
EntryName
AF1L2_HUMAN
FullName
Actin filament-associated protein 1-like 2
TaxID
9606
Evidence
evidence at protein level
Length
818
SequenceStatus
complete
DateCreated
2005-06-21
DateModified
2021-06-02
Ontological Relatives
Genes
AFAP1L2
GO terms
Show/Hide Table
GO
Name
GO:0005737
cytoplasm
GO:0005829
cytosol
GO:0005886
plasma membrane
GO:0006954
inflammatory response
GO:0007346
regulation of mitotic cell cycle
GO:0017124
SH3 domain binding
GO:0030296
protein tyrosine kinase activator activity
GO:0032675
regulation of interleukin-6 production
GO:0032757
positive regulation of interleukin-8 production
GO:0035591
signaling adaptor activity
GO:0042169
SH2 domain binding
GO:0045742
positive regulation of epidermal growth factor receptor signaling pathway
GO:0045893
positive regulation of transcription, DNA-templated
Subcellular Location
Show/Hide Table
Subcellular Location
Cytoplasm
Domains
Show/Hide Table
Domain
Name
Category
Type
IPR001849
Pleckstrin homology domain
Domain
Domain
IPR011993
PH-like domain superfamily
Family
Homologous superfamily
IPR030113
Actin-filament associated protein
Family
Family
IPR030115
Actin filament-associated protein 1-like 2
Family
Family
Diseases
Show/Hide Table
Drugs
Show/Hide Table
Interactions
10 interactions
Interactor
Partner
Sources
Publications
Link
AF1L2_HUMAN
TERF1_HUMAN
bhf-ucl, BioGRID
21044950
details
AF1L2_HUMAN
TERF2_HUMAN
bhf-ucl, BioGRID
21044950
details
AF1L2_HUMAN
TINF2_HUMAN
bhf-ucl, BioGRID
21044950
details
AF1L2_HUMAN
ACD_HUMAN
bhf-ucl, BioGRID
21044950
details
AF1L2_HUMAN
POTE1_HUMAN
bhf-ucl, BioGRID
21044950
details
AF1L2_HUMAN
ATX1L_HUMAN
BioGRID
16713569
details
AF1L2_HUMAN
A4_HUMAN
BioGRID
21832049
details
AF1L2_HUMAN
SPD2A_HUMAN
BioGRID
26446840
details
AF1L2_HUMAN
SRC_HUMAN
BioGRID, HPRD
17412687
26446840
details
AF1L2_HUMAN
RASA1_HUMAN
HPRD
17412687
details
This website requires cookies in order to function. By using the site you are agreeing to this as outlined in our
Terms of Use
I Agree